Working groups
Dr Sherrie Kelly is an infectious disease modeller specialising in applied health economics. She has over 15 years of experience working with countries across all income levels and global regions, as well as with a wide range of national and international organisations. Dr Kelly has a background in epidemiology and global health with focus on HIV, TB, and maternal-child health.
Dr Kelly leads the Burnet Institute's Optima group on HIV, TB, and malaria modeling applications and research, as well as facilitates Optima training workshops and country missions. Prior to joining the Optima team, Dr Kelly worked with UNAIDS and the Public Health Agency of Canada, having experience in infectious disease emergency response and basic laboratory research.
Swaziland is presently in the process of developing its HIV investment case, with a specific focus on prioritizing high-impact interventions. To initiate this process, the Government of Swaziland and UNAIDS have solicited assistance from the World Bank to estimate the potential impact of these high-impact interventions through mathematical modeling. The World Bank, in turn, contracted the HIV modeling team at UNSW Australia to undertake this task. The following report provides a summary of the outcomes derived from this modeling effort.
HIV Mathematical Modelling to Support Swaziland's Development of its HIV Investment Case.The Lancet HIV
Tom Walsh, Debra ten Brink, Anna L. Bowring, Rowan Martin‐Hughes, Nisaa Wulan, Yinzong Xiao, Kelvin Burke, Tom Tidhar, Sherrie L. Kelly, Nick Scott
The Lancet HIV
Tom Walsh, Debra ten Brink, Anna L. Bowring, Rowan Martin‐Hughes, Nisaa Wulan, Yinzong Xiao, Kelvin Burke, Tom Tidhar, Sherrie L. Kelly, Nick Scott
JAIDS Journal of Acquired Immune Deficiency Syndromes
Sherrie L. Kelly, Rowan Martin‐Hughes